Category: Artificial Intelligence

Explore our library of blogs, insights, research papers, and more information on compliance in the life sciences industry.

The Life Sciences Industry’s Regulatory Outlook in 2024

As we step into 2024, life sciences companies continue to introduce innovative treatments to the market that improve patient health while adhering to the rules and regulations enacted by the regulatory authorities and identifying and mitigating compliance risks. While data-driven compliance platforms are enabling compliance professionals to ensure compliance with the evolving rules and regulations, […]

8 Best Practices To Ensure Compliance with Open Payments Sunshine Act

The Physician Payments Sunshine Act requires life sciences companies to report any payments or other transfers of value made to physicians and teaching hospitals to the Centers for Medicare & Medicaid Services (CMS) “Physicians” include those legally authorized to practice medicine, osteopathy, dentistry, dental surgery, podiatry, optometry, and chiropractic medicine. Over the years, life sciences companies […]

The Importance of Risk Mitigation in the Life Sciences Industry

Life sciences risk monitoring is a critical component of ensuring compliance and operational integrity in a highly regulated industry. Life sciences companies operate under strict regulations, overseen by bodies such as the U.S. Department of Justice (DOJ) and the Office of Inspector General (OIG). This intricate regulatory environment requires organizations to adopt robust risk mitigation […]

Sunshine Act Reporting/Transparency Reporting: Explained

Before delving into the mechanics of Sunshine Act reporting, it is useful to reflect on the history and rationale behind this significant piece of legislation. The Physician Payments Sunshine Act, now known simply as the Sunshine Act, was signed into law by President Barack Obama on March 23, 2010, as part of the Patient Protection […]

Data-Driven HCP Engagement Strategies for Life Sciences Companies in 2024

In the pharmaceutical industry, maintaining compliance with the laws and regulations is paramount. The Anti-kickback (AKS) Law prohibits the exchange of any form of remuneration to induce or reward referrals of federal healthcare program business. Violations can lead to severe penalties, including fines, imprisonment, and exclusion from federal healthcare programs. As such, pharmaceutical compliance professionals […]

The Latest Trends in Expense Monitoring & Auditing in 2024

Life Sciences companies face significant challenges ensuring accuracy and transparency in expense monitoring and auditing. To address these challenges, a few trends have emerged. Each time life sciences companies think they are on top of compliance requirements, rules and regulations change. This generally mounts pressure on compliance teams and drains the organizations of their time […]